Affiliation:
1. School of Life Science, Shanghai University, 99 Shangda Road, Shanghai 200444, China
2. National Engineering Laboratory of Southwest Endangered Medicinal Resources Development, Guangxi Botanical Garden of Medicinal Plants, Nanning, China
3. Zhongshan Hospital, Institute of Clinical Science, Shanghai Medical College, Fudan University, Shanghai, China
Abstract
ANO1, anoctamin 1(also known as TMEM16A), is the molecular basis of calcium-activated
chloride channels with ten transmembrane segments which are widely expressed in mammalian
cells, including epithelial cells, vascular smooth muscle tissues, electro-excitatory cells, and
some tumor cells. To date, multiple studies have shown that many natural and synthetic compounds
have regulatory effects on ANO1. Therefore, ANO1 could be a potential new drug target
for the treatment of cancer, pain, diarrhea, hypertension, and asthma. In this study, we review the
structure of ANO1 and its involvement in cancer, pain, diarrhea, hypertension, and asthma.
Funder
Open Funding of Key Laboratory of Diagnosis and Treatment of Severe Hepato-pancreatic Diseases of Zhejiang Province
National Natural Science Foundation of China
Natural Science Foundation of Shanghai
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献